Preview

Tumors of female reproductive system

Advanced search

MEMBRANE LEc EXPRESSION IN BREAST CANCER CELLS

https://doi.org/10.17650/1994-4098-2009-0-3-4-43-48

Abstract

Affine chromatography was used to isolate Lec antibodies from the sera of a healthy female donor with the high titers of these anti- bodies, which were labeled with biotin. The study enrolled 51 patients with primary breast cancer (BC). Antigen expression was found by immunohistochemistry and flow cytometry. With these two techniques being used, the detection rate of Lec expression in BC cells was 65% (33/51); the antigen was most frequently found by flow cytometry as compared with immunohistochemistry: 72 and 58% of cases, respectively.

About the Authors

Ya. A. Udalova
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation


N. V. Bovin
M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow
Russian Federation


P. S. Obukhova
M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow
Russian Federation


N. V. Shilova
M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow
Russian Federation


A. M. Kovrigina
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation


A. A. Subbotina
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation


V. V. Timoshenko
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation


O. E. Galanina
M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow
Russian Federation


Z. G. Kadagidze
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation


V. P. Letyagin
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation


N. N. Tupitsyn
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation


References

1. Vollmers H.P., Brandlein S. Nature’s best weapons to fight cancer. Revival of human monoclonal IgM antibodies. Hum Antibodies 2002;11(2):131—42.

2. Brandlein S., Vollmers H.P. Natural IgM antibodies, the ignored weapons in tumour immunity. Histol Histopathol 2004;19(3):897—905.

3. Vollmers H.P., Brandlein S. Natural IgM antibodies: from parias to parvenus. Histol Histopathol 2006;21(12):1355—66.

4. Vollmers H.P., Brandlein S. Natural IgM antibodies: the orphaned molecules in immune surveillance. Histol Histopathol 2006;58(5—6):755—65.

5. Bohn J. Are natural antibodies involved in tumour defence. Immunol Let 1999;69(3):317—20.

6. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol 2000;37(18):1141—9.

7. Kasaian M.T., Casali P. Autoimmunity-prone (CD5 B) cells, nat- ural antibodies and self-recognition. Autoimmunity 1993;15(4):315—29.

8. Bofill M., Janossy G., Janossa M. et al. Human B-cell development. II. Subpopulations in human fetus. J Immunol 1985;134(3):1531—8.

9. Brandlein S., Pohle T., Ruoff N. et al. Natural IgM antibodies and immunosur- veillance mechanisms against epithelial cancer cells in humans. Cancer Res 2003;63:7995—8005.

10. Pohle T., Brandlein S., Ruoff N. et al. Lipoptosis: a tumor-specific cell death by antibody-induced intracellular lipid accu- mulation. Cancer Res 2004;64:3900—6.

11. Rye P.D., Walker R.A. Prognostic value of breast cancer-associated glyco- protein detected by monoclonal antibody Lu-BCRU-G7. Eur J Cancer 1994;30(7):1007—12.

12. Rye P.D., Bovin N.V., Vlasova E.V., Walker R.A. Monoclonal antibody LU- BCRU-G7 against a breast tumor-associ- ated glycoprotein recognizes the disac- charide Gal beta1-3GlcNAc. Glycobiology 1995;5(4):385—9.

13. Тупицын Н.Н., Летягин В.П., П ниченко А.В. и др. Новые иммунологические маркеры (CD71, LU-BCRU- G7), взаимосвязанные с прогнозом рака молочной железы. Совр онкол 2001;3(4):161—3.

14. Тупицын Н.Н., Галанина О.Е., Бовин Н.В. и др. Уровень специфических антител к углеводному антигену Lec понижен у больных раком молочной железы. Иммунология 2008;(2):31—3.

15. Tupitsyn N.N., Kadagidze Z.G., Tuichiev I.K. et al. Relationship between semiquantitative and quantitative parameters of local immune response in gastric cancer. Exper oncol 1995;17:31—6.

16. Rye P.D., Bovin N.V. Selection of carbohydrate-binding cell phenotypes using oligosaccharide-coated magnetic particles. Glycobiology 1997;7(2):179—82.

17. Vollmers H.P., Zimmerman U., Krenn U. et al. Adjuvant therapy for gas- tric adenocarcinoma with apoptosis- inducing human monoclonal antibody SC-1: first clinical and histopathological results. Oncol Rep 1998;5:549—52.

18. Beutner U., Lorenz U., Illert B. et al. Neoadjuvant therapy of gastric cancer with human monoclonal IgM antibody SC-1: impact on immune system. Oncol Rep 2008;19:761—9.

19. Illert B., Otto C., Vollmers H.P. et al. Human antibody SC-1 reduces dissemi- nated tumor cells in nude mice with human gastric cancer. Oncol Rep 2005;13(4):765—70.

20. Крохина О.В., Летягин В.П., Тупицын Н.Н. и др. Иммуноцитологическая диагностика микрометастазов рака молочной железы в костный мозг. Иммунол гемопоэз 2007—2008;5—6:116—31.


Review

For citations:


Udalova Ya.A., Bovin N.V., Obukhova P.S., Shilova N.V., Kovrigina A.M., Subbotina A.A., Timoshenko V.V., Galanina O.E., Kadagidze Z.G., Letyagin V.P., Tupitsyn N.N. MEMBRANE LEc EXPRESSION IN BREAST CANCER CELLS. Tumors of female reproductive system. 2009;(3-4):43-48. (In Russ.) https://doi.org/10.17650/1994-4098-2009-0-3-4-43-48

Views: 860


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1994-4098 (Print)
ISSN 1999-8627 (Online)